-+ 0.00%
-+ 0.00%
-+ 0.00%

Quantum BioPharma wins FDA clearance for Lucid-MS Phase 2 trial

PUBT·09/11/2026 12:30:45
Listen to the news
Quantum BioPharma wins FDA clearance for Lucid-MS Phase 2 trial
  • Quantum BioPharma secured FDA clearance to start a Phase 2 trial of Lucid-MS in multiple sclerosis.
  • Lucid-MS targets protection or potential rebuilding of the myelin sheath rather than immune suppression.
  • The company framed the program as a first-in-class human test of this mechanism in MS.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Biopharma Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609110830PRIMZONEFULLFEED9824892) on September 11, 2026, and is solely responsible for the information contained therein.